Kurt W. Tauer, MD, FACP, discusses the expansion of subtyping in breast cancer.
Kurt W. Tauer, MD, FACP
Advertisement
Articles by Kurt W. Tauer, MD, FACP
Kurt W. Tauer, MD, FACP, discusses the potential implications of biosimilars on cancer research funding.
Advertisement
Latest Updated Articles
Dr. Tauer on the Expansion of Subtyping in Breast CancerJanuary 16th 2020
Advertisement
Advertisement
Trending on OncLive
1
Managing Long-Term Toxicities and Emerging Therapies in ALK-Positive NSCLC
2
Five Under 5: Top Oncology Videos for the Week of 6/28
3
The OncFive: Top Oncology Articles for the Week of 6/28
4
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera
5